$17.97 Million in Sales Expected for OptiNose, Inc. (NASDAQ:OPTN) This Quarter

Wall Street analysts forecast that OptiNose, Inc. (NASDAQ:OPTN – Get Rating) will announce sales of $17.97 million for the current quarter, Zacks reports. Two analysts have issued estimates for OptiNose’s earnings, with the highest sales estimate coming in at $18.00 million and the lowest estimate coming in at $17.93 million. OptiNose reported sales of $11.96 […]

Related Keywords

Helena Kyttari Djupesland ,Gisle Djupesland ,Peterk Miller ,Securities Exchange Commission ,Goldman Sachs Group Inc ,Zacks Investment Research ,Stonepine Capital Management ,Blackrock Inc ,Renaissance Technologies ,De Shaw Co ,Nasdaq ,Optinose Company Profile Get Rating ,Optinose Inc ,Wall Street ,Get Rating ,Investment Research ,Exchange Commission ,Sachs Group ,Capital Management ,Nose Company Profile ,Per Gisle Djupesland ,Optinose ,Nasdaq Optn ,Optn ,Medical ,Ratings ,Consensus ,